HealthQuill immune overactivity
Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Health Research

Key protein ArfGAP2 identified as driver of autoimmune diseases

HQ Team March 20, 2025: Researchers have identified a protein, ArfGAP2, that triggers harmful immune responses in autoimmune diseases, offering a novel target.

Read More